Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,192 stories indexed, page 105 of 154

🇬🇧Researchhdruk.ac.uk

MyEyeSite: creating a patient-owned repository of inherited retinal disease data

Health Data Research UKOriginal source
🇩🇰Industryserviersymphogen.com

Servier underskriver endelig aftale om at erhverve Symphogen, en førende antistof discovery virksomhed, for at styrke Serviers kapacitet inden for antistoffer samt dets forskning og udvikling

SymphogenOriginal source
🇩🇰Industryserviersymphogen.com

Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline

SymphogenOriginal source
🇺🇸Researchcidrap.umn.edu

News Scan for Apr 02, 2020

CIDRAPOriginal source
🇺🇸Researchcidrap.umn.edu

Stewardship / Resistance Scan for Apr 02, 2020

CIDRAPOriginal source
🇧🇪Regulatoryfamhp.be

Pilot project on simultaneous national scientific advice starts 1 February 2020

FAMHP (Belgium)Original source
🇺🇸CDMOnoramco.com

Meet us at DCAT Week

NoramcoOriginal source
🌍Industryan2therapeutics.com

AN2 Therapeutics Launches with $12 Million in Series A

AN2 TherapeuticsOriginal source
🌍Industryemzorpharma.com

Emzor Wellocracy Radio Show with Pharm Tosin Oguntoye

Emzor PharmaceuticalOriginal source
🌍Industryemzorpharma.com

Emzor Wellocracy Radio Show with Pharm Funmbi Okoya

Emzor PharmaceuticalOriginal source
🌍Industryemzorpharma.com

Emzor Wellocracy Radio Show with Pharm Kehinde Adepoju

Emzor PharmaceuticalOriginal source
🌍Industryemzorpharma.com

Emzor Wellocracy Radio Show with Pharm Muyiwa Olagunju

Emzor PharmaceuticalOriginal source
🇺🇸Researchcidrap.umn.edu

Stewardship / Resistance Scan for Aug 30, 2019

CIDRAPOriginal source
🇺🇸CROflorencehc.com

Why Remote Clinical Trial Monitoring is the New Standard

Florence HealthcareOriginal source
🌍Industryir.cyclerion.com

Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months

Cyclerion TherapeuticsOriginal source
🇺🇸CROflorencehc.com

Overcoming Four Common Challenges in Multicenter Research

Florence HealthcareOriginal source
🌍Industrycervomed.com

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma Appoints Noel Donnelly as CFO - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Huntington's Disease - CervoMed

CervoMedOriginal source
🇺🇸CROflorencehc.com

Integrating the eTMF and eISF: Why and Why Now?

Florence HealthcareOriginal source
🌍Industrycervomed.com

EIP Pharma to Host KOL Breakfast Briefing on Potential of Neflamapimod in Alzheimer's Disease and Dementia with Lewy Bodies - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma to Present at Upcoming Investor Conferences in June - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma to Present at BIO CEO Investor Conference - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma Announces Phase 2B REVERSE-SD Study of Neflamapimod Fully Enrolled - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma Announces Clinical Study Presentations at the 11th Clinical Trials on Alzheimer's Disease Conference and Provides Update on Phase 2b Clinical Study Enrollment - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma Secures $20.5 Million in Series B Financing - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma Announces Publication of Positive Alzheimer's Disease Clinical Study Data with Neflamapimod - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma announces presentation of new mechanism of action data regarding neflamapimod (VX-745) at Alzheimer's Association International Conference (AAIC) - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma announces presentation of new positive clinical data with neflamapimod (VX-745) at Alzheimer's Association International Conference (AAIC) - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma announces positive results with neflamapimod (VX-745) in two Phase 2a clinical trials in patients with Early Alzheimer's Disease - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma announces issuance of multiple new patents covering VX-745, a selective p38 MAP kinase alpha inhibitor for Alzheimer's disease and ischemic stroke recovery - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma announces scientific publication of results demonstrating pro-cognitive effects in aged rats of VX-745, a clinical stage selective p38 MAP kinase alpha Inhibitor - CervoMed

CervoMedOriginal source
🌍Industrycervomed.com

EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) - CervoMed

CervoMedOriginal source
🇺🇸CROflorencehc.com

Technology in Multicenter Clinical Trials

Florence HealthcareOriginal source
🌍Industryemzorpharma.com

AFCON 2019 Kicks Off Today!

Emzor PharmaceuticalOriginal source
🌍Industryir.cyclerion.com

Cyclerion Therapeutics to Present Preclinical Data on its Clinical-Stage sGC Stimulators for Neurodegenerative and Cardiometabolic Diseases at the 9th International Conference on cGMP

Cyclerion TherapeuticsOriginal source
🌍Industryemzorpharma.com

Dr Stella Okoli, CEO Emzor Pharmaceutical to be Inducted into Nigerian Women Hall of Fame by Federal Government

Emzor PharmaceuticalOriginal source
🌍Industryir.cyclerion.com

Cyclerion Therapeutics to Present Data on its Sickle Cell Disease Program at Upcoming Medical and Scientific Meetings

Cyclerion TherapeuticsOriginal source
🌍Industryemzorpharma.com

Emzor Para 1000 Features in Music Video, Ringi Ringi by Akuchi Ft. Olamide

Emzor PharmaceuticalOriginal source
🇩🇰Industryserviersymphogen.com

Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials

SymphogenOriginal source
🇩🇰Industryserviersymphogen.com

Symphogen announces new capital raise and explores strategic options

SymphogenOriginal source
🌍Industryir.cyclerion.com

Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company

Cyclerion TherapeuticsOriginal source
🌍Industryir.cyclerion.com

Cyclerion to Host Corporate Overview Call on May 13, 2019

Cyclerion TherapeuticsOriginal source
🇺🇸CROflorencehc.com

FDA: Technology’s Value in a World of Precision Medicine and Research

Florence HealthcareOriginal source
🌍Industryir.cyclerion.com

Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer

Cyclerion TherapeuticsOriginal source
🌍Industryir.cyclerion.com

Cyclerion Launches as Clinical-Stage Biopharmaceutical Company Harnessing the Power of Soluble Guanylate Cyclase (sGC) Pharmacology for Treatment of Serious and Orphan Diseases

Cyclerion TherapeuticsOriginal source
🇺🇸CROflorencehc.com

ALCOA-C in Clinical Trial Electronic Document Management

Florence HealthcareOriginal source
🇺🇸Researchcidrap.umn.edu

Stewardship / Resistance Scan for Mar 18, 2019

CIDRAPOriginal source
🌍Industryemzorpharma.com

Emzor’s Position on the BBC Documentary on Codeine

Emzor PharmaceuticalOriginal source
🇺🇸Researchcidrap.umn.edu

Antibiotics before miscarriage surgery not tied to fewer infections

CIDRAPOriginal source
🌍Industryir.cyclerion.com

Cyclerion, the Planned R&D Spin-off of Ironwood Pharmaceuticals, Secures Commitments of $175 Million in Private Offering

Cyclerion TherapeuticsOriginal source
🇺🇸CROflorencehc.com

5 Key Advantages of eRegulatory

Florence HealthcareOriginal source
🇺🇸CROflorencehc.com

Observations from TMF Summit 2019: The Post-eTMF World

Florence HealthcareOriginal source
🌍Industryir.cyclerion.com

Ironwood Announces Filing of Form 10 Registration Statement in Connection with Planned Business Separation

Cyclerion TherapeuticsOriginal source
🇺🇸CROflorencehc.com

How Lauren Begnaud Transitioned 65 Sites to eRegulatory at US Oncology

Florence HealthcareOriginal source
🇺🇸CROflorencehc.com

Thank you for a great 2018!

Florence HealthcareOriginal source
🇺🇸CROflorencehc.com

Key Expectations of Clinical Trial Operations Leaders in 2019

Florence HealthcareOriginal source
🇺🇸CROflorencehc.com

Four Observations from Site Solutions Summit

Florence HealthcareOriginal source